Revenue Breakdown
Composition ()
No data
Revenue Streams
cbdMD Inc (YCBD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is E-commerce sales, accounting for 77.7% of total sales, equivalent to $3.58M. Another important revenue stream is Wholesale sales. Understanding this composition is critical for investors evaluating how YCBD navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, cbdMD Inc maintains a gross margin of 54.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.71%, while the net margin is -5.64%. These profitability ratios, combined with a Return on Equity (ROE) of -68.90%, provide a clear picture of how effectively YCBD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, YCBD competes directly with industry leaders such as PMCB and ASBP. With a market capitalization of $8.09M, it holds a leading position in the sector. When comparing efficiency, YCBD's gross margin of 54.93% stands against PMCB's N/A and ASBP's 45.54%. Such benchmarking helps identify whether cbdMD Inc is trading at a premium or discount relative to its financial performance.
